Cargando…

Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity

Krüppel-like factor 2 (KLF2) is a transcription factor with significant roles in development, maturation, differentiation, and proliferation of several cell types. In immune cells, KLF2 regulates maturation and trafficking of lymphocytes and monocytes. KLF2 participates in regulation of the nuclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Pernaa, Nora, Keskitalo, Salla, Chowdhury, Iftekhar, Nissinen, Antti, Glumoff, Virpi, Keski-Filppula, Riikka, Junttila, Juhani, Eklund, Kari K., Santaniemi, Wenny, Siitonen, Sanna, Seppänen, Mikko RJ., Vähäsalo, Paula, Varjosalo, Markku, Åström, Pirjo, Hautala, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716311/
https://www.ncbi.nlm.nih.gov/pubmed/36466816
http://dx.doi.org/10.3389/fimmu.2022.819929
_version_ 1784842659922182144
author Pernaa, Nora
Keskitalo, Salla
Chowdhury, Iftekhar
Nissinen, Antti
Glumoff, Virpi
Keski-Filppula, Riikka
Junttila, Juhani
Eklund, Kari K.
Santaniemi, Wenny
Siitonen, Sanna
Seppänen, Mikko RJ.
Vähäsalo, Paula
Varjosalo, Markku
Åström, Pirjo
Hautala, Timo
author_facet Pernaa, Nora
Keskitalo, Salla
Chowdhury, Iftekhar
Nissinen, Antti
Glumoff, Virpi
Keski-Filppula, Riikka
Junttila, Juhani
Eklund, Kari K.
Santaniemi, Wenny
Siitonen, Sanna
Seppänen, Mikko RJ.
Vähäsalo, Paula
Varjosalo, Markku
Åström, Pirjo
Hautala, Timo
author_sort Pernaa, Nora
collection PubMed
description Krüppel-like factor 2 (KLF2) is a transcription factor with significant roles in development, maturation, differentiation, and proliferation of several cell types. In immune cells, KLF2 regulates maturation and trafficking of lymphocytes and monocytes. KLF2 participates in regulation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway. Although pulmonary arterial hypertension (PAH) related to KLF2 genetic variant has been suggested, genetic role of KLF2 associated with immune dysregulation has not been described. We identified a family whose members suffered from lymphopenia, autoimmunity, and malignancy. Whole exome sequencing revealed a KLF2 p.(Glu318Argfs*87) mutation disrupting the highly conserved zinc finger domain. We show a reduced amount of KLF2 protein, defective nuclear localization and altered protein-protein interactome. The phenotypically variable positive cases presented with B and T cell lymphopenia and abnormalities in B and T cell maturation including low naive T cell counts and low CD27(+)IgD(-)IgM(-) switched memory B cells. KLF2 target gene (CD62L) expression was affected. Although the percentage of (CD25(+)FOXP3(+), CD25(+)CD127(-)) regulatory T cells (Treg) was high, the naive Treg cells (CD45RA(+)) were absent. Serum IgG1 levels were low and findings in one case were consistent with common variable immunodeficiency (CVID). Transcription of NF-κβ pathway genes and p65/RelA phosphorylation were not significantly affected. Inflammasome activity, transcription of genes related with JAK/STAT pathway and interferon signature were also comparable to controls. Evidence of PAH was not found. In conclusion, KLF2 variant may be associated with familial immune dysregulation. Although the KLF2 deficient family members in our study suffered from lymphopenia, autoimmunity or malignancy, additional study cohorts are required to confirm our observations.
format Online
Article
Text
id pubmed-9716311
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97163112022-12-03 Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity Pernaa, Nora Keskitalo, Salla Chowdhury, Iftekhar Nissinen, Antti Glumoff, Virpi Keski-Filppula, Riikka Junttila, Juhani Eklund, Kari K. Santaniemi, Wenny Siitonen, Sanna Seppänen, Mikko RJ. Vähäsalo, Paula Varjosalo, Markku Åström, Pirjo Hautala, Timo Front Immunol Immunology Krüppel-like factor 2 (KLF2) is a transcription factor with significant roles in development, maturation, differentiation, and proliferation of several cell types. In immune cells, KLF2 regulates maturation and trafficking of lymphocytes and monocytes. KLF2 participates in regulation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway. Although pulmonary arterial hypertension (PAH) related to KLF2 genetic variant has been suggested, genetic role of KLF2 associated with immune dysregulation has not been described. We identified a family whose members suffered from lymphopenia, autoimmunity, and malignancy. Whole exome sequencing revealed a KLF2 p.(Glu318Argfs*87) mutation disrupting the highly conserved zinc finger domain. We show a reduced amount of KLF2 protein, defective nuclear localization and altered protein-protein interactome. The phenotypically variable positive cases presented with B and T cell lymphopenia and abnormalities in B and T cell maturation including low naive T cell counts and low CD27(+)IgD(-)IgM(-) switched memory B cells. KLF2 target gene (CD62L) expression was affected. Although the percentage of (CD25(+)FOXP3(+), CD25(+)CD127(-)) regulatory T cells (Treg) was high, the naive Treg cells (CD45RA(+)) were absent. Serum IgG1 levels were low and findings in one case were consistent with common variable immunodeficiency (CVID). Transcription of NF-κβ pathway genes and p65/RelA phosphorylation were not significantly affected. Inflammasome activity, transcription of genes related with JAK/STAT pathway and interferon signature were also comparable to controls. Evidence of PAH was not found. In conclusion, KLF2 variant may be associated with familial immune dysregulation. Although the KLF2 deficient family members in our study suffered from lymphopenia, autoimmunity or malignancy, additional study cohorts are required to confirm our observations. Frontiers Media S.A. 2022-11-18 /pmc/articles/PMC9716311/ /pubmed/36466816 http://dx.doi.org/10.3389/fimmu.2022.819929 Text en Copyright © 2022 Pernaa, Keskitalo, Chowdhury, Nissinen, Glumoff, Keski-Filppula, Junttila, Eklund, Santaniemi, Siitonen, Seppänen, Vähäsalo, Varjosalo, Åström and Hautala https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Pernaa, Nora
Keskitalo, Salla
Chowdhury, Iftekhar
Nissinen, Antti
Glumoff, Virpi
Keski-Filppula, Riikka
Junttila, Juhani
Eklund, Kari K.
Santaniemi, Wenny
Siitonen, Sanna
Seppänen, Mikko RJ.
Vähäsalo, Paula
Varjosalo, Markku
Åström, Pirjo
Hautala, Timo
Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity
title Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity
title_full Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity
title_fullStr Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity
title_full_unstemmed Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity
title_short Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity
title_sort heterozygous premature termination in zinc-finger domain of krüppel-like factor 2 gene associates with dysregulated immunity
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716311/
https://www.ncbi.nlm.nih.gov/pubmed/36466816
http://dx.doi.org/10.3389/fimmu.2022.819929
work_keys_str_mv AT pernaanora heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT keskitalosalla heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT chowdhuryiftekhar heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT nissinenantti heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT glumoffvirpi heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT keskifilppulariikka heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT junttilajuhani heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT eklundkarik heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT santaniemiwenny heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT siitonensanna heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT seppanenmikkorj heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT vahasalopaula heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT varjosalomarkku heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT astrompirjo heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity
AT hautalatimo heterozygousprematureterminationinzincfingerdomainofkruppellikefactor2geneassociateswithdysregulatedimmunity